$28.3 Million is the total value of ABG-WTT Global Life Science Capital Partners GP Ltd's 3 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDVL | Buy | MEDAVAIL HOLDINGS INC | $22,995,000 | +509.3% | 15,029,480 | +286.8% | 81.12% | +164.8% |
| RAPID MICRO BIOSYSTEMS INC | $4,465,000 | -36.7% | 1,038,296 | 0.0% | 15.75% | -72.5% | ||
| LUNG | PULMONX CORP | $886,000 | -40.7% | 60,204 | 0.0% | 3.13% | -74.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 11 | Q2 2023 | 92.0% |
| PULMONX CORP | 11 | Q2 2023 | 49.0% |
| RAPID MICRO BIOSYSTEMS INC | 6 | Q2 2023 | 57.2% |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 4 | 2022-04-06 |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.